Abstract
Diabetes mellitus is a common disease among patients with pancreatic cancer and chronic pancreatitis, disorders of the exocrine pancreas. Different clinical features of diabetes are associated with these two conditions: hyperinsulinemia and peripheral insulin resistance are the prevailing diabetic traits in pancreatic cancer, whereas reduced islet cell mass and impaired insulin secretion are typically observed in chronic pancreatitis. Whether or not a causal relationship exists between diabetes and pancreatic carcinoma is an intriguing but unanswered question. Diabetes often precedes pancreatic cancer and is thus regarded as a potential risk factor for malignancy. Conversely, pancreatic cancer may secrete diabetogenic factors. Given these findings, there is increasing interest in whether close monitoring of the glycemic profile may aid early detection of pancreatic tumor lesions.
Key words
pancreatic cancer - chronic pancreatitis - diabetes mellitus
References
-
1
ADA .
Type 2 diabetes in children and adolescents. American Diabetes Association.
Diabetes Care.
2000;
23
((3))
381-389
-
2
Bank S.
Chronic pancreatitis: clinical features and medical management.
Am J Gastroenterol.
1986;
81
((3))
153-167
-
3
Basso D, Greco E, Fogar P, Pucci P, Flagiello A, Baldo G, Giunco S, Valerio A, Navaglia F, Zambon CF, Falda A, Pedrazzoli S, Plebani M.
Pancreatic cancer-derived S-100A8 N-terminal peptide: a diabetes cause?.
Clin Chim Acta.
2006;
372
((1–2))
120-128
-
4
Basso D, Greco E, Fogar P, Pucci P, Flagiello A, Baldo G, Giunco S, Valerio A, Navaglia F, Zambon CF, Pedrazzoli S, Plebani M.
Pancreatic cancer-associated diabetes mellitus: an open field for proteomic applications.
Clin Chim Acta.
2005;
357
((2))
184-189
-
5
Basso D, Valerio A, Seraglia R, Mazza S, Piva MG, Greco E, Fogar P, Gallo N, Pedrazzoli S, Tiengo A, Plebani M.
Putative pancreatic cancer-associated diabetogenic factor: 2030 MW peptide.
Pancreas.
2002;
24
((1))
8-14
-
6
Bonelli L, Aste H, Bovo P, Cavallini G, Felder M, Gusmaroli R, Morandini E, Ravelli P, Briglia R, Lombardo L, Micheli A De, Pugliese V.
Exocrine pancreatic cancer, cigarette smoking, and diabetes mellitus: A case-control study in Northern Italy.
Pancreas.
2003;
27
((2))
143-149
-
7
Bowker SL, Majumdar SR, Veugelers P, Johnson JA.
Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin.
Diabetes Care.
2006;
29
((2))
254-258
-
8
Brand RE, Lerch MM, Rubinstein WS, Neoptolemos JP, Whitcomb DC, Hruban RH, Brentnall TA, Lynch HT, Canto MI.
Advances in counselling and surveillance of patients at risk for pancreatic cancer.
Gut.
2007;
56
((10))
1460-1469
-
9
Bright R.
Cases and observations connected with disease of the pancreas and duodenum.
Med Chir Trans.
1833;
18
1-56
-
10 Bruns C, Diebold J, Heinemann V, Wilkowski R, Wagner A, Schmid R. Karzinome des exokrinen Panreas und der periampullären Region. In: Sendler, A. (ed). Manual Gastrointestinale Tumoren – Empfehlungen zur Diagnostik, Therapie und Nachsorge. München: Zuckschwerdt Verlage 2006: 77-99
-
11
Büchler MW, Friess H, Müller MW, Wheatley AM, Beger HG.
Randomized trial of duodenum-preserving pancreatic head resection versus pylorus-preserving Whipple in chronic pancreatitis.
Am J Surg.
1995;
169
((1))
65-69
, ; discussion 69–70
-
12
Chari ST, Klee GG, Miller LJ, Raimondo M, Magno EP Di.
Islet amyloid polypeptide is not a satisfactory marker for detecting pancreatic cancer.
Gastroenterology.
2001;
121
((3))
640-645
-
13
Chari ST, Leibson CL, Rabe KG, Ransom J, Andrade M de, Petersen GM.
Probability of pancreatic cancer following diabetes: a population-based study.
Gastroenterology.
2005;
129
((2))
504-511
-
14
Chari ST, Leibson CL, Rabe KG, Timmons LJ, Ransom J, Andrade M de, Petersen GM.
Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer.
Gastroenterology.
2008;
134
((1))
95-101
-
15
Czyzyk A, Szczepanik Z.
Diabetes mellitus and cancer.
Eur J Intern Med.
2000;
11
((5))
245-252
-
16
Damiano J, Bordier L, Le Berre JP, Mrgery J, Dupuy O, Mayaudon H, Bauduceau B.
Should pancreas imaging be recommanded in patients over 50 years when diabetes is discovered because of acute symptoms?.
Diabetes Metab.
2004;
30
((2))
203-207
-
17
Davalli AM, Pontiroli AE, Bertuzzi F, Pozza G, Socci C, Carlo V Di, Freschi M.
In vitro function of human islets isolated from the pancreas of a cadaveric donor with diabetes mellitus secondary to chronic pancreatitis.
Pancreas.
1994;
9
((1))
134-136
-
18
Everhart J, Wright D.
Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis.
JAMA.
1995;
273
((20))
1605-1609
-
19
Fisher WE, Boros LG, Schirmer WJ.
Insulin promotes pancreatic cancer: evidence for endocrine influence on exocrine pancreatic tumors.
J Surg Res.
1996;
63
((1))
310-313
-
20
Fisher WE, Muscarella P, Boros LG, Schirmer WJ.
Variable effect of streptozotocin-diabetes on the growth of hamster pancreatic cancer (H2T) in the Syrian hamster and nude mouse.
Surgery.
1998;
123
((3))
315-320
-
21
Fogar P, Basso D, Pasquali C, Piva MG, Brigato L, Paoli M De, Galeotti F, Corsini A, Plebani M.
Portal but not peripheral serum levels of interleukin 6 could interfere with glucose metabolism in patients with pancreatic cancer.
Clin Chim Acta.
1998;
277
((2))
181-189
-
22
Fogar P, Pasquali C, Basso D, Sperti C, Panozzo MP, Tessari G, DAngeli F, Del Favero G, Plebani M.
Diabetes mellitus in pancreatic cancer follow-up.
Anticancer Res.
1994;
14
((6B))
2827-2830
-
23
Friedman GD, Eeden SK van den.
Risk factors for pancreatic cancer: an exploratory study.
Int J Epidemiol.
1993;
22
((1))
30-37
-
24
Frye JN, Inder WJ, Dobbs BR, Frizelle FA.
Pancreatic cancer and diabetes: is there a relationship? A case-controlled study.
Aust N Z J Surg.
2000;
70
((10))
722-724
-
25
Fryzek JP, Garabrant DH, Schenk M, Kinnard M, Greenson JK, Sarkar FH.
The association between selected risk factors for pancreatic cancer and the expression of p53 and K-ras codon 12 mutations.
Int J Gastrointest Cancer.
2006;
37
((4))
139-145
-
26
Gavin JR, Alberti KGMM, Davidson MB, DeFronzo RA, Drash A, Gabbe SG, Genuth S, Harris MI, Kahn R, Keen H, Knowler WC, Lebovitz H, Maclaren NK, Palmer JP, Raskin P, Rizza RA, Stern MP.
Report of the expert committee on the diagnosis and classification of diabetes mellitus.
Diabetes Care.
2003;
S5-20
-
27
Goto M, Nakano I, Kimura T, Miyahara T, Kinjo M, Nawata H.
New chronic pancreatitis model with diabetes induced by cerulein plus stress in rats.
Dig Dis Sci.
1995;
40
((11))
2356-2363
-
28
Gullo L.
Diabetes and the risk of pancreatic cancer.
Ann Oncol.
1999;
10
((Suppl 4))
79-81
-
29
Gullo L, Pezzilli R, Morselli-Labate AM.
Diabetes and the risk of pancreatic cancer. Italian Pancreatic Cancer Study Group.
N Engl J Med.
1994;
331
((2))
81-84
-
30
Gupta S, Vittinghoff E, Bertenthal D, Corley D, Shen H, Walter LC, MacQuaid K.
New-onset diabetes and pancreatic cancer.
Clin Gastroenterol Hepatol.
2006;
4
((11))
1366-1372
, ; quiz 1301.
-
31
Gupta V, Toskes PP.
Diagnosis and management of chronic pancreatitis.
Postgrad Med J.
2005;
81
((958))
491-497
-
32
Hedetoft C, Sheikh SP, Larsen S, Holst JJ.
Effect of glucagon-like peptide 1(7–36) amide in insulin-treated patients with diabetes mellitus secondary to chronic pancreatitis.
Pancreas.
2000;
20
((1))
25-31
-
33
Hjalgrim H, Frisch M, Ekbom A, Kyvik KO, Melbye M, Green A.
Cancer and diabetes – a follow-up study of two population-based cohorts of diabetic patients.
J Intern Med.
1997;
241
((6))
471-475
-
34
Hull RL, Westermark GT, Westermark P, Kahn SE.
Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes.
J Clin Endocrinol Metab.
2004;
89
((8))
3629-3643
-
35
Huxley R, Ansary-Moghaddam A, Berrington de Gonzalez A, Barzi F, Woodward M.
Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies.
Br J Cancer.
2005;
92
((11))
2076-2083
-
36
Isaksson B, Strommer L, Friess H, Buchler MW, Herrington MK, Wang F, Zierath JR, Wallberg-Henriksson H, Larsson J, Permert J.
Impaired insulin action on phosphatidylinositol 3-kinase activity and glucose transport in skeletal muscle of pancreatic cancer patients.
Pancreas.
2003;
26
((2))
173-177
-
37
Ishikawa O, Ohhigashi H, Wada A, Tateishi R, Ishiguro S, Okano Y, Sasaki Y, Imaoka S, Koyama H, Iwanaga T.
Morphologic characteristics of pancreatic carcinoma with diabetes mellitus.
Cancer.
1989;
64
((5))
1107-1112
-
38
Ishikawa O, Ohigashi H, Imaoka S, Nakai I, Mitsuo M, Weide L, Pour PM.
The role of pancreatic islets in experimental pancreatic carcinogenicity.
Am J Pathol.
1995;
147
((5))
1456-1464
-
39
Ito T, Otsuki M, Itoi T, Shimosegawa T, Funakoshi A, Shiratori K, Naruse S, Kuroda Y.
Pancreatic diabetes in a follow-up survey of chronic pancreatitis in Japan.
J Gastroenterol.
2007;
42
((4))
291-297
-
40
Klöppel G, Bommer G, Commandeur G, Heitz P.
The endocrine pancreas in chronic pancreatitis. Immunocytochemical and ultrastructural studies.
Virchows Arch A Pathol Anat Histol.
1978;
377
((2))
157-174
-
41
Litwin J, Dobrowolski S, Orlowska-Kunikowska E, Sledzinski Z.
Changes in glucose metabolism after Kausch-Whipple pancreatectomy in pancreatic cancer and chronic pancreatitis patients.
Pancreas.
2008;
36
((1))
26-30
-
42
Liu J, Kazakoff K, Pour PM, Adrian TE.
The intracellular mechanism of insulin resistance in the hamster pancreatic ductal adenocarcinoma model.
Pancreas.
1998;
17
((4))
359-366
-
43
Liu J, Knezetic JA, Strommer L, Permert J, Larsson J, Adrian TE.
The intracellular mechanism of insulin resistance in pancreatic cancer patients.
J Clin Endocrinol Metab.
2000;
85
((3))
1232-1238
-
44
Malka D, Hammel P, Sauvanet A, Rufat P, O’Toole D, Bardet P, Belghiti J, Bernades P, Ruszniewski P, Levy P.
Risk factors for diabetes mellitus in chronic pancreatitis.
Gastroenterology.
2000;
119
((5))
1324-1332
-
45
Michaud DS, Wolpin B, Giovannucci E, Liu S, Cochrane B, Manson JE, Pollak MN, Ma J, Fuchs CS.
Prediagnostic plasma C-peptide and pancreatic cancer risk in men and women.
Cancer Epidemiol Biomarkers Prev.
2007;
16
((10))
2101-2109
-
46
Monami M, Lamanna C, Pala L, Bardini G, Cresci B, Francesconi P, Balzi D, Marchionni N, Rotella CM, Mannucci E.
Treatment with insulin secretagogues and cancer-related mortality in type 2 diabetic patients a retrospective cohort study.
Exp Clin Endocrinol Diabetes.
2008;
116
((3))
184-189
-
47
Mossner J, Logsdon CD, Williams JA, Goldfine ID.
Insulin, via its own receptor, regulates growth and amylase synthesis in pancreatic acinar AR42J cells.
Diabetes.
1985;
34
((9))
891-897
-
48
Nyboe Andersen B, Krarup T, Thorsgaard Pedersen NT, Faber OK, Hagen C, Worning H.
B cell function in patients with chronic pancreatitis and its relation to exocrine pancreatic function.
Diabetologia.
1982;
23
((2))
86-89
-
49
Oosterwijk C, Hulst KL van, Visser CJ, Woutersen RA, Lips CJ, Tweel JG van den, Hoppener JW.
Pancreatic cancer in rats and hamsters does not induce IAPP-related hyperglycaemia.
Int J Cancer.
1997;
72
((4))
637-641
-
50
Opie E.
On the relation of chronic interstitial pancreatitis to the islands of Langerhans and to diabetes mellitus.
J exp Med.
1901;
5
((4))
397-428
-
51
Pelaez-Luna M, Takahashi N, Fletcher JG, Chari ST.
Resectability of presymptomatic pancreatic cancer and its relationship to onset of diabetes: a retrospective review of CT scans and fasting glucose values prior to diagnosis.
Am J Gastroenterol.
2007;
102
((10))
2157-2163
-
52
Permert J, Adrian TE, Jacobsson P, Jorfelt L, Fruin AB, Larsson J.
Is profound peripheral insulin resistance in patients with pancreatic cancer caused by a tumor-associated factor?.
Am J Surg.
1993a;
165
((1))
61-66
, ; discussion 66–67
-
53
Permert J, Ihse I, Jorfeldt L, Schenck H von, Arnqvist HJ, Larsson J.
Pancreatic cancer is associated with impaired glucose metabolism.
Eur J Surg.
1993b;
159
((2))
101-107
-
54
Permert J, Larsson J, Fruin AB, Tatemoto K, Herrington MK, Schenck H von, Adrian TE.
Islet hormone secretion in pancreatic cancer patients with diabetes.
Pancreas.
1997;
15
((1))
60-68
-
55
Permert J, Larsson J, Westermark GT, Herrington MK, Christmanson L, Pour PM, Westermark P, Adrian TE.
Islet amyloid polypeptide in patients with pancreatic cancer and diabetes.
N Engl J Med.
1994;
330
((5))
313-318
-
56
Permert J, Mogaki M, Andren-Sandberg A, Kazakoff K, Pour PM.
Pancreatic mixed ductal-islet tumors. Is this an entity?.
Int J Pancreatol.
1992;
11
((1))
23-29
-
57
Perrin MC, Terry MB, Kleinhaus K, Deutsch L, Yanetz R, Tiram E, Calderon R, Friedlander Y, Paltiel O, Harlap S.
Gestational diabetes as a risk factor for pancreatic cancer: a prospective cohort study.
BMC Med.
2007;
5
25
-
58
Pour PM, Duckworth W, Carlson K, Kazakoff K.
Insulin therapy prevents spontaneous recovery from streptozotocin-induced diabetes in Syrian hamsters. An autoradiographic and immunohistochemical study.
Virchows Arch A Pathol Anat Histopathol.
1990;
417
((4))
333-341
-
59
Pour PM, Stepan K.
Modification of pancreatic carcinogenesis in the hamster model. VIII. Inhibitory effect of exogenous insulin.
J Natl Cancer Inst.
1984;
72
((5))
1205-1208
-
60
Pour PM, Weide L, Liu G, Kazakoff K, Scheetz M, Toshkov I, Ikematsu Y, Fienhold MA, Sanger W.
Experimental evidence for the origin of ductal-type adenocarcinoma from the islets of Langerhans.
Am J Pathol.
1997;
150
((6))
2167-2180
-
61
Ragozzino M, Melton
3rd
LJ, Chu CP, Palumbo PJ.
Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus.
J Chronic Dis.
1982;
35
((1))
13-19
-
62
Schneider MB, Matsuzaki H, Haorah J, Ulrich A, Standop J, Ding XZ, Adrian TE, Pour PM.
Prevention of pancreatic cancer induction in hamsters by metformin.
Gastroenterology.
2001;
120
((5))
1263-1270
-
63
Silverman DT, Swanson CA, Gridley G, Wacholder S, Greenberg RS, Brown LM, Hayes RB, Swanson GM, Schoenberg JB, Pottern LM, Schwartz AG, Fraumeni
Jr
JF, Hoover RN.
Dietary and nutritional factors and pancreatic cancer: a case-control study based on direct interviews.
J Natl Cancer Inst.
1998;
90
((22))
1710-1719
-
64
Slebos RJC, Hoppin JA, Tolbert PE, Holly EA, Brock JW, Zhang RH, Bracci PM, Foley J, Stockton P, MacGregor LM, Flake GP, Taylor JA.
K-ras and p53 in pancreatic cancer: Association with Medical History, Histopathology, and Environmental Exposures in a Population-based Study.
Cancer Epidemiol Biomarkers Prev.
2000;
9
((11))
1223-1232
-
65
Steer ML, Waxman I, Freedman S.
Chronic pancreatitis.
N Engl J Med.
1995;
332
((22))
1482-1490
-
66
Stevens RJ, Roddam AW, Beral V.
Pancreatic cancer in type 1 and young-onset diabetes: systematic review and meta-analysis.
Br J Cancer.
2007;
96
((3))
507-509
-
67
Tateishi K, Magno EP Di, Klee GG.
Plasma islet amyloid polypeptide is not an effective tumor marker for pancreatic cancer even when protease inhibitors and rapid freezing of specimens are utilized.
Clin Chem.
2001;
47
((11))
2071-2073
-
68
Uygur-Bayramicli O, Dabak R, Orbay E, Dolapcioglu C, Sargin M, Kilicoglu G, Guleryuzlu Y, Mayadagli A.
Type 2 diabetes mellitus and CA 19-9 levels.
World J Gastroenterol.
2007;
13
((40))
5357-5359
-
69
Wakasugi H, Funakoshi A, Iguchi H.
Clinical observations of pancreatic diabetes caused by pancreatic carcinoma, and survival period.
Int J Clin Oncol.
2001;
6
((1))
50-54
-
70
Wang F, Gupta S, Holly EA.
Diabetes mellitus and pancreatic cancer in a population-based case-control study in the San Francisco Bay Area, California.
Cancer Epidemiol Biomarkers Prev.
2006;
15
((8))
1458-1463
-
71
Westermark P, Wernstedt C, Wilander E, Hayden DW, O’Brien TD, Johnson KH.
Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells.
Proc Natl Acad Sci USA.
1987;
84
((11))
3881-3885
-
72 WHO .Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Geneva 1999
-
73
Woods SC, Lutz TA, Geary N, Langhans W.
Pancreatic signals controlling food intake; insulin, glucagon and amylin.
Philos Trans R Soc Lond B Biol Sci.
2006;
361
((1471))
1219-1235
-
74
Zendehdel K, Nyren O, Ostenson CG, Adami HO, Ekbom A, Ye W.
Cancer incidence in patients with type 1 diabetes mellitus: a population-based cohort study in Sweden.
J Natl Cancer Inst.
2003;
95
((23))
1797-1800
-
75
Zimmet P, Alberti KG, Shaw J.
Global and societal implications of the diabetes epidemic.
Nature.
2001;
414
((6865))
782-787
Correspondence
Prof. Dr. M. SolimenaMD, PhD
Experimental Diabetology
Medical School Carl Gustav Carus
University of Technology Dresden
Fetscherstraße 74
01307 Dresden
Germany
Phone: +49/351/458 66 12
Fax: +49/351/458 63 30
Email: Michele.Solimena@tu-dresden.de
Correspondence
Prof. Dr. med. H. D. Saeger
Klinik und Poliklinik für Viszeral-, Thorax- und Gefäßchirurgie
Universitätsklinikum Carl Gustav Carus an der TU Dresden
Fetscherstraße 74
01307 Dresden
Germany
Phone: +49/351/458 27 42
Fax: +49/351/458 43 95
Email: Hans-Detlev.Saeger@uniklinikum-dresden.de
